A new prognostic instrument specifically designed for patients irradiated for recurrent carcinoma of the bladder

Lisa Manig, Stefan Janssen, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background/Aim: To develop an instrument that could estimate the 1-year survival probabilities of patients irradiated for recurrent carcinoma of the bladder. Patients and Methods: Thirty patients irradiated for locally recurrent bladder carcinoma were included. Six pre-treatment factors [age, gender, Karnofsky score (KPS), pack years, grading and time between cancer diagnosis and radiotherapy] were evaluated for survival. Of those factors showing a trend or significance on multivariate analysis, 1-year survival rates were added. Results: On multivariate analysis, KPS was significant (hazard ratio(HR)=3.76, p=0.008), age showed a trend (HR=2.04, p=0.13). Patient scores were five, nine, ten or fourteen points with 1-year survival rates of 13%, 25%, 57% and 82% (p=0.003). Three groups were designed, A (5-9 points), B (10 points) and C (14 points) with 1-year survival rates of 17%, 57% and 82% (p=0.001). Conclusion: This score, including three groups with different 1-year survival probabilities, can aid physicians treating patients with recurrent bladder carcinoma.

Original languageEnglish (US)
Pages (from-to)435-438
Number of pages4
JournalIn Vivo
Volume31
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Hazards
Urinary Bladder
Carcinoma
Radiotherapy
Survival Rate
Survival
Multivariate Analysis
Age Factors
Physicians
Neoplasms
Therapeutics

Keywords

  • Irradiation
  • Locally recurrent carcinoma of the bladder
  • Pre-treatment factors
  • Predictive score
  • Survival

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

A new prognostic instrument specifically designed for patients irradiated for recurrent carcinoma of the bladder. / Manig, Lisa; Janssen, Stefan; Schild, Steven E.; Rades, Dirk.

In: In Vivo, Vol. 31, No. 3, 01.05.2017, p. 435-438.

Research output: Contribution to journalArticle

Manig, Lisa ; Janssen, Stefan ; Schild, Steven E. ; Rades, Dirk. / A new prognostic instrument specifically designed for patients irradiated for recurrent carcinoma of the bladder. In: In Vivo. 2017 ; Vol. 31, No. 3. pp. 435-438.
@article{025bb305e00945709c367fb99901b344,
title = "A new prognostic instrument specifically designed for patients irradiated for recurrent carcinoma of the bladder",
abstract = "Background/Aim: To develop an instrument that could estimate the 1-year survival probabilities of patients irradiated for recurrent carcinoma of the bladder. Patients and Methods: Thirty patients irradiated for locally recurrent bladder carcinoma were included. Six pre-treatment factors [age, gender, Karnofsky score (KPS), pack years, grading and time between cancer diagnosis and radiotherapy] were evaluated for survival. Of those factors showing a trend or significance on multivariate analysis, 1-year survival rates were added. Results: On multivariate analysis, KPS was significant (hazard ratio(HR)=3.76, p=0.008), age showed a trend (HR=2.04, p=0.13). Patient scores were five, nine, ten or fourteen points with 1-year survival rates of 13{\%}, 25{\%}, 57{\%} and 82{\%} (p=0.003). Three groups were designed, A (5-9 points), B (10 points) and C (14 points) with 1-year survival rates of 17{\%}, 57{\%} and 82{\%} (p=0.001). Conclusion: This score, including three groups with different 1-year survival probabilities, can aid physicians treating patients with recurrent bladder carcinoma.",
keywords = "Irradiation, Locally recurrent carcinoma of the bladder, Pre-treatment factors, Predictive score, Survival",
author = "Lisa Manig and Stefan Janssen and Schild, {Steven E.} and Dirk Rades",
year = "2017",
month = "5",
day = "1",
doi = "10.21873/invivo.11079",
language = "English (US)",
volume = "31",
pages = "435--438",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - A new prognostic instrument specifically designed for patients irradiated for recurrent carcinoma of the bladder

AU - Manig, Lisa

AU - Janssen, Stefan

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background/Aim: To develop an instrument that could estimate the 1-year survival probabilities of patients irradiated for recurrent carcinoma of the bladder. Patients and Methods: Thirty patients irradiated for locally recurrent bladder carcinoma were included. Six pre-treatment factors [age, gender, Karnofsky score (KPS), pack years, grading and time between cancer diagnosis and radiotherapy] were evaluated for survival. Of those factors showing a trend or significance on multivariate analysis, 1-year survival rates were added. Results: On multivariate analysis, KPS was significant (hazard ratio(HR)=3.76, p=0.008), age showed a trend (HR=2.04, p=0.13). Patient scores were five, nine, ten or fourteen points with 1-year survival rates of 13%, 25%, 57% and 82% (p=0.003). Three groups were designed, A (5-9 points), B (10 points) and C (14 points) with 1-year survival rates of 17%, 57% and 82% (p=0.001). Conclusion: This score, including three groups with different 1-year survival probabilities, can aid physicians treating patients with recurrent bladder carcinoma.

AB - Background/Aim: To develop an instrument that could estimate the 1-year survival probabilities of patients irradiated for recurrent carcinoma of the bladder. Patients and Methods: Thirty patients irradiated for locally recurrent bladder carcinoma were included. Six pre-treatment factors [age, gender, Karnofsky score (KPS), pack years, grading and time between cancer diagnosis and radiotherapy] were evaluated for survival. Of those factors showing a trend or significance on multivariate analysis, 1-year survival rates were added. Results: On multivariate analysis, KPS was significant (hazard ratio(HR)=3.76, p=0.008), age showed a trend (HR=2.04, p=0.13). Patient scores were five, nine, ten or fourteen points with 1-year survival rates of 13%, 25%, 57% and 82% (p=0.003). Three groups were designed, A (5-9 points), B (10 points) and C (14 points) with 1-year survival rates of 17%, 57% and 82% (p=0.001). Conclusion: This score, including three groups with different 1-year survival probabilities, can aid physicians treating patients with recurrent bladder carcinoma.

KW - Irradiation

KW - Locally recurrent carcinoma of the bladder

KW - Pre-treatment factors

KW - Predictive score

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85018718008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018718008&partnerID=8YFLogxK

U2 - 10.21873/invivo.11079

DO - 10.21873/invivo.11079

M3 - Article

VL - 31

SP - 435

EP - 438

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 3

ER -